John Lilleyman
Sir John Stuart Lilleyman (born 9 July 1945) is a British paediatric haematologist.[1] His specialization is childhood leukemia and idiopathic thrombocytopenic purpura.[2] CareerLilleyman contributed to the testing of leukemia treatment methods and conducted research on "thiopurine metabolism" in children with leukemia.[2] He was president of the Royal College of Pathologists during the Alder Hey organs scandal.[2] During that time, he was vice-chairman of the Academy of the Medical Royal Colleges.[2] In 2004, he became medical director of the National Patient Safety Agency (NPSA).[3] Awards and honoursIn 1991, the Royal College of Pathologists awarded him its first Distinguished Service Medal for establishing the United Kingdom's system of pathology laboratory accreditation.[4] He was appointed president of the Royal Society of Medicine in 2004.[3] Selected publicationsBooks
References
External links
|